UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath works with a technology known as agentic automation, which is the process of using artificial intelligence to carry out multi-step tasks quickly with limited human input. U ...

UiPath (NYSE: PATH) is on the path to a full market reversal because its March price pullback is an irrational response to good news. The company's Q4 fiscal year 2026 (FY2026) results topped ...

UiPath works with a technology known as agentic automation, which is the process of using artificial intelligence to carry out multi-step tasks quickly with limited human input. U ...

エージェンティックオートメーションのグローバルリーダーであるUiPath株式会社（本社：東京都千代田区、カントリーマネージャー：南 哲夫、以下「UiPath」）は、本日エージェンティックオートメーションを実現する次世代のプラットフォーム、UiPath Platform ...

UiPath, Inc. PATH will release earnings results for its fourth quarter, after the closing bell on Wednesday, March 11. Analysts expect the New York-based company to report quarterly earnings at 26 ...